XZXi Zhan

Xi Zhan

*This is an algorithmically generated author record based on publicly available information.

Xi Zhan has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A nomogram-based clinical prediction model for adverse clinical outcomes in non-HIV Pneumocystis jirovecii pneumonia patients

    by Dong Wang, Lujia Guan, Qian Yin, Xiaoxia Hou, Xi Zhan, Zhaohui Tong

    Background: Non-human immunodeficiency virus (HIV) immunocompromised patients with Pneumocystis jirovecii pneumonia (PJP) face rapid progression and high mortality, necessitating a predictive model to identify patients at risk of adverse clinical outcomes for timely interventions and improved stratification. Methods: Patients admitted between January 2011 and June 2024 at Beijing Chao-Yang Hospital were retrospectively analyzed. Collected data included patients’ demographics, smoking status, comorbidities, immunosuppressive diseases, blood laboratory tests, in-hospital treatment, and adverse clinical outcomes. Predictor selection was performed using the least absolute shrinkage and selection operator (LASSO) and logistic regression, with selected features incorporated into a nomogram. Internal validation was conducted using a 500-bootstrap resampling method to ensure model robustness. Model performance was assessed via the area under the receiver operating curve (AUC), calibration plots, decision curve analysis (DCA), and clinical impact curve (CIC). Results: Among the 431 patients, 243 (56.4%) experienced adverse clinical outcomes. LASSO regression screened 21 variables, selecting 9 predictors with non-zero coefficients through 10-fold cross-validation at lambda.1se = 0.0453 (log(lambda.1se) = -3.092). Multivariate logistic regression identified 7 independent risk factors for adverse clinical outcomes: smoking status, cytomegalovirus infection, diabetes, neutrophil-lymphocyte ratio (NLR), lactate dehydrogenase (LDH), PaO2/FiO2 (PFR), and lymphocyte subset. These factors were incorporated into a nomogram, achieving an AUC of 0.89 (95% CI: 0.86–0.92), with the Hosmer–Lemeshow test (p = 0.134) and calibration curves showing strong agreement between predicted and observed outcomes. Internal validation via 500-bootstrap resampling yielded a bias-corrected AUC of 0.83 (95% CI: 0.80–0.86). DCA demonstrated strong clinical decision-making utility, while the CIC confirmed its practical reliability. Conclusions: Regression analysis identified smoking status, CMV infection, diabetes, NLR, LDH, PFR, and lymphocyte subset as independent risk factors for adverse clinical outcomes in non-HIV PJP patients. The predictive model constructed from these factors exhibited robust accuracy and reliability.


  • Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study

    by Shuqiao Yang, Dandan Chai, Yihua Li, Yuanying Wang, Xi Zhan, Liming Zhang, Jing Wang, Qiao Ye

    Objectives This study aimed to explore differences in clinical features and prognosis among patients with varied myeloperoxidase (MPO) antineutrophil cytoplasmic antibody-associated vasculitis (MPO-AAV) associated lung diseases. Methods Patients with MPO-AAV-associated lung diseases were enrolled in this retrospective cohort study at a single center. Clinical features and laboratory data at the time of diagnosis were compared among patients with various lung disease patterns. Kaplan–Meier and Cox regression analyses were performed to analyze overall survival. Results A total of 155 patients were finally included and categorized into five groups, as follows: 72 had a usual interstitial pneumonia (UIP) pattern, 40 had non-UIP interstitial pneumonia, 18 had bronchiectasis (BR), 13 had necrotizing granuloma (NG), and 12 had diffuse alveolar hemorrhage (DAH). Among the five groups, patients with DAH had higher dyspnea and hemoptysis frequencies, lower PaO2/FiO2 levels, elevated C-reactive protein levels, and the poorest prognosis. The overall survival (OS) in the DAH group (median OS: 3.2 months) was significantly poorer than that in the NG group (median OS: not reached, log rank P < 0.001), the BR group (median OS: not reached, log rank P < 0.001), and the non-UIP IP group (median OS: 61.1 months, log rank P = 0.001). The UIP group had significantly more ex-smokers than the other groups (P < 0.001) and the second poorest survival (median OS: 39.1 months). The NG group tended to have female predominance, a higher incidence of ENT involvement, less severe renal involvement, and the best survival. After adjusting for multi-model Cox regression analysis, DAH and UIP (hazard ratio: 19.301 and 9.940, respectively, compared with NG) were independent predictors of all-cause mortality. Conclusions Various patterns of lung disease-associated MPO-AAV may potentially predict patient survival. Key Point • The present study described the clinical and prognostic features of various lung diseases-associated MPO-AAV, indicating the potential prediction for the survival of MPO-AAV patients.


  • Open Access

    Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

    by Xi Zhan, Wei Yan, Ying Wang, Qing Li, Xuhua Shi, Yanli Gao, Qiao Ye

    Background: Anti-synthetase syndrome (ASSD) is a chronic autoimmune condition characterized by antibodies directed against an aminoacycl transfer RNA synthetase (ARS) along with a group of clinical features including the classical clinical triad: inflammatory myopathy, arthritis, and interstitial lung disease (ILD). ASSD is highly heterogenous due to different organ involvement, and ILD is the main cause of mortality and function loss, which presents as different patterns when diagnosed. We designed this retrospective cohort to describe the clinical features and disease behaviour of ASSD associated ILD. Methods: Data of 108 cases of ASSD associated ILD were retrospectively collected in Beijing Chaoyang Hospital from December 2017 to March 2019. Data were obtained from the Electronic Medical Record system. Patients were divided into 5 groups according to distinct aminoacyl tRNA synthetase (ARS) antibodies. Results: Overall, 108 consecutive patients were recruited. 33 were JO-1 positive, 30 were PL-7 positive, 23 were EJ positive, 13 were PL-12 positive and 9 were OJ positive. The JO-1 (+) group had a significant higher rate of mechanic’s hand (57.6%) than other 4 groups. Polymyositis/dermatomyositis (PM/DM) was diagnosed in 25 (23.1%) patients and no difference was observed among the 5 groups. The PL-7 (+) group had a higher frequency of UIP pattern (13.3%) than the other 4 groups but the difference was not significant, and the EJ (+) group had the most frequent OP pattern (78.2%), which was significantly higher than the PL-7 (+) (P < 0.001) and PL-12 (+) groups (P = 0.025). The median follow-up time was 10.7 months, during which no patients died. All received prednisone treatment, with or without immunosuppressants. At the 6-month follow-up, 96.3% of all patients (104/108) had a positive response to therapy, the JO-1 (+) and EJ (+) groups had a significantly higher improvement of forced vital capacity than the other 3 groups (P < 0.05), and the PL-7 group had the lowest FVC improvement (P < 0.05). The JO-1 (+) group and EJ (+) group had significantly higher anti-Ro-52 positive occurrence than the other 3 groups (P < 0.05). Conclusion: Anti PL-7 antibody had the same frequency as anti-JO-1 in ASSD-ILD, in which the ILD pattern was different with distinct anti-ARS antibodies. Most ASSD-ILD had a positive response to steroid therapies, with or without immunosuppressants. The PL-7 (+) group had the highest occurrence of UIP pattern, and a significantly lower response to therapy.


  • Open Access

    Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

    by Xi Zhan, Yan Wei, Wang Ying, Li Qing, Shi Xuhua, Gao Yanli, Ye Qiao

    BackgroundAnti-synthetase syndrome (ASSD) is a chronic autoimmune condition characterized by antibodies directed against an aminoacycl transfer RNA synthetase (ARS) along with a group of clinical features including the classical clinical triad: inflammatory myopathy, arthritis, and interstitial lung disease (ILD). ASSD is highly heterogenous due to different organ involvement, and ILD is the main cause of mortality and function loss, which presents as different patterns when diagnosed. We designed this retrospective cohort to describe the clinical features and disease behaviour of ASSD associated ILD. MethodsData of 108 cases of ASSD associated ILD were retrospectively collected in Beijing Chaoyang Hospital from 2017.12 to 2019.3. Data were obtained from the Electronic Medical Record (EMR) system. Patients were divided into 5 groups according to distinct aminoacyl tRNA synthetase (ARS) antibodies. Results:Overall, 108 consecutive patients were recruited. 33 were JO-1 positive,30 were PL-7 positive,23 were EJ positive, 13 were PL12 positive and 9were OJ positive. The JO-1 group had a significant higher rate of mechanic’s hand (57.6%) than other 4 groups. Polymyositis/ dermatomyositis (PM/DM) was diagnosed in 25 (23.1%) patients and no difference was observed among the 5 groups. The anti-PL7 positive group had a higher frequency of UIP pattern (13.3%) than the other 4 groups but the difference was not significant, and the EJ group had the most frequent OP pattern(78.2%), which was significantly higher than the PL-7 (PConclusionAnti PL-7 antibody had the same frequency as anti-JO1 in ASSD-ILD, in which the ILD pattern was different with distinct anti-ARS antibodies. Most ASSD-ILD had a positive response to steroid therapies, with or without immunosuppressants. The PL-7 group had the highest occurrence of UIP pattern, and a significantly lower response to therapy.

  • Open Access

    Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone

    by Xi Zhan, Zhigang Zhao, Ting Li

    The coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) has led to a pandemic situation.


  • Open Access

    Clinical features of Anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

    by Xi Zhan, Yan Wei, Wang Ying, Li Qing, Shi Xuhua, Gao Yanli, Ye Qiao

    Background Antisynthetase Syndrome (ASSD) is a chronic autoimmune condition characterized by antibodies directed against an aminoacycl transfer RNA synthetase (ARS) along with a group of clinical features including the classical clinical triad: inflammatory myopathy, arthritis, interstitial lung disease (ILD). ASSD is highly heterogenous due to the different organs involvement, and ILD is the main cause of mortality and function loss, which presents as different patterns when diagnosed. We designed this retrospective cohort to describe the clinical features and disease behavior of the ASSD) associated ILD. Methods Retrospectively collected the data of 108 cases of ASSD associated ILD in Beijing Chaoyang Hospital since 2017.12 to 2019.3. Data including age, gender, physical examination, laboratory test, pulmonary function and High Resolution Computer Tomography (HRCT), treatment, were obtained from the Electronic Medical Record (EMR) system. Patients were divided into 5 groups according to the distinct Aminoacyl tRNA synthetases (ARS) antibodies, and all patients had a multiple discussion team (MDT) to make a radiological and pathological diagnosis of the ILD pattern. Each patient had at least 1 follow up for no less than 6 months. Patients with missing data of MDT evaluation or follow up were excluded. Results: 108 consecutive patients were recruited in this retrospective cohort. 30 cases received bronchoscopy for a transbronchial lung biopsy. 3 had bronchoscopy for a transbronchial cryobiopsy. 33 were with JO-1 positive and 30 were with PL-7 positive. 23 with EJ positive, 13 with PL12 positive and 9 with OJ positive. JO-1 group had a significant higher rate of mechanic’s hand (57.6%) than other 4 groups, the skin involvement (Gottron Papules and/or Heliotrope Rash) was found in 38 (35%) and no difference was found among the 5 groups. Polymyositis/Dermatomyositis (PM/DM) was diagnosed in 25 (23.1%) patients and no difference was observed among the 5 groups. The anti-PL7 positive group had a higher frequency of UIP pattern (13.3%) than other 4 groups but the difference was not significant due to the small sample size, and EJ group had the most frequent OP pattern(78.2%), which was significantly higher than PL-7 group (P<0.001) and PL-12 group (P=0.025). The median follow-up time were 10.7 months. All received prednisone treatment, with or without immunosuppressants ,and at the 6-month-follow up, the JO-1 group and EJ group had the significantly higher improvement of forced vital capacity that the other 3 groups (P<0.05), and PL-7 group had the lowest FVC improvement (P<0.05). The anti-Jo1-positive group and anti-EJ-positive group had significantly higher anti-RO52-positive occurrence than other 3 groups (P<0.05).Conclusion Anti PL-7 antibody had the same frequency as anti-JO1 in ASSD-ILD, in which the ILD pattern was different with distinct anti-ARS antibodies. All ASSD-ILD responded to therapy of steroids, with or without immunosuppressants. PL-7 group had a highest occurrence of UIP pattern, and significantly lower respondence to therapy.

  • Open Access

    A Rare Missense Variant in Telomerase Reverse Transcriptase is Associated with Idiopathic Pulmonary Fibrosis in a Chinese Han Family

    by Chun-Ming Zheng, Xi Zhan, Yuan-Hua Yang, Tao Jiang, Qiao Ye, Yong Lu

    Background: Idiopathic pulmonary fibrosis (IPF) is an age-related and progressive interstitial lung disease. Up to 20% of cases of IPF cluster in families, genetic factors contribute significantly to the pathogenesis of the disease. This study aimed to explore the association between rare genetic variants and IPF in Chinese Han families. Methods: A Han family, comprising three IPF patients and five unaffected their first-degree relatives, and 100 ethnically matched control individuals from North China were enrolled in this study. Peripheral blood was collected, and genomic DNA was extracted. To elucidate if rare genetic variants are associated with the familial IPF, we performed whole-exome sequencing of affected members from a Chinese Han IPF family. Candidate rare variants were then confirmed by Sanger sequencing. Results: We identified a potentially damaging rare variant-a heterozygous mutation c.2146G>A in exon 6 of the gene encoding for telomerase reverse transcriptase (TERT), which results in an amino acid substitution (p.Ala716Thr). We confirmed the missense mutation by Sanger sequencing in all the affected family members but did not detect this mutation in 100 ethnically matched healthy controls. Patients carried this mutation were characterized by the frequently acute exacerbation of IPF phenotype, with poor prognosis. The mean time to death was 2.8 years after diagnosis. Conclusion: Using next-generation sequencing technology in familial IPF patients, we identified the heterozygous rare variant in TERT gene, and strengthened the importance of genetic variants in telomere-related pathogenesis in Chinese IPF patients. TERT 基因的罕见错义突变与中国汉族家族特发性肺纤维化相关 摘要 背景:特发性肺纤维化(IPF)是一种和年龄相关的进展性间质性肺疾病。多达20%的IPF患者呈现家族聚集性,遗传因素在IPF发病过程中起到重要作用。本研究的目的是探寻罕见遗传变异与中国汉族家族特发性肺纤维化的相关性。 方法:收集了一个中国汉族IPF家系,包含3例IPF患者和5名非患病一级亲属。同时收集了100名与上述IPF患者性别、年龄相匹配的非患病的中国北方汉族人作为对照。所有受试者采集外周血提取DNA。为了研究罕见遗传变异是否与家族性IPF相关,我们对该家系的IPF患者进行了全外显子组测序。候选罕见变异位点采用Sanger测序证实。 结果:我们在该家系发现了一个可能致病的罕见变异位点,该杂合变异c.2146G>A位于端粒逆转录酶基因(TERT)的第6外显子区,导致p.Ala716Thr错义突变。Sanger测序在家系中证实了该变异,在100名对照受试者中未检测到该变异。携带该突变的IPF患者表现为频繁急性加重表型,预后差,诊断后平均生存时间为2.8年。 结论:通过对家族性IPF进行新一代测序技术分析,我们发现了与疾病相关的TERT基因的罕见变异,在中国IPF患者中进一步证实了遗传变异在端粒相关致病机制中的重要作用。